|
Glioblastoma
|
|
|
E. Galanis,
J. C. Buckner, M. J. Maurer, M. Hidalgo, J. I. Kreisberg, J. Peralba, R.
B. Jenkins, D. J. Walsh
N997B: Phase II Trial of
CCI-779 in Recurrent Glioblastoma Mutiforme (GBM): Updated Results and
Correlative Laboratory Analysis
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1505. (Clinical
Study)
Journal of Clinical Oncology, Vol 23,
No 16S (June 1 Supplement), 2005: 1505
|
|
E. Galanis, J. C. Buckner, M.
Maurer, K. Ballman, M. Hidalgo, J. I. Kreisberg, J. Boni, C. D. D. James, R. B.
Jenkins, D. J. Walsh
NCCTG phase II trial of CCI-779 in recurrent
glioblastoma multiforme (GBM)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1503 (Clinical
Study)
|
|
Mischel PS, Cloughesy TF
Targeted
molecular therapy of GBM
Brain Pathol. 2003
Jan;13(1):52-61
(Review Article,
Abstract)
|
|
